Verastem Oncology Competitors and Similar CompaniesClear all

Verastem Oncology's competitors and similar companies include Mirati Therapeutics and InxMed.
Verastem Oncology
Verastem Oncology
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
Mirati Therapeutics
Mirati Therapeutics
Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
InxMed
InxMed
InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines.
Founding Date
Founding Date
2010
Founding Date
2013
Founding Date
2018
Type
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Needham, US HQ
Walsrode, DE
Locations
San Diego, US HQ
Zug, CH
Locations
HQ
Employees
Employees
7328% increase
Employees
666% decrease
Employees
17

Financial

Revenue (est.)
Revenue (est.)
$30.9m (FY, 2025)
Revenue (est.)
$12.4m (FY, 2022)
Revenue (est.)
N/A
Net income
Net income
($209.5m) (FY, 2025)
Net income
($740.9m) (FY, 2022)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 170m
Total funding raised
N/A
Total funding raised
$ 19m
For sources of this data, please see the company profile

View Company Profiles

Mirati Therapeutics
HQ
San Diego, US

Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.

View company
InxMed
HQ
Employees
17

InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines.

View company